| MELAX | VEIEX | MELAX / VEIEX | |
| Total Expense Ratio | 1.35 | 0.29 | 466% |
| Annual Report Gross Expense Ratio | 1.60 | 0.29 | 552% |
| Fund Existence | 11 years | 32 years | - |
| Gain YTD | 10.180 | 10.824 | 94% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 104M | 163B | 0% |
| Annual Yield % from dividends | 0.00 | 2.29 | - |
| Returns for 1 year | 14.29 | 23.69 | 60% |
| Returns for 3 years | 30.71 | 53.66 | 57% |
| Returns for 5 years | -12.17 | 20.32 | -60% |
| Returns for 10 years | 83.37 | 108.76 | 77% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BUIMX | 14.27 | 0.16 | +1.13% |
| Buffalo Mid Cap Growth Inst | |||
| JIUCX | 21.23 | 0.18 | +0.86% |
| JPMorgan Developed International Value C | |||
| MACEX | 21.09 | 0.15 | +0.72% |
| ClearBridge Emerging Markets A | |||
| VSGIX | 98.79 | 0.38 | +0.39% |
| Vanguard Small Cap Growth Index I | |||
| TCPWX | 12.70 | 0.04 | +0.32% |
| Transamerica Capital Growth R6 | |||